CDX-2 and MIB-1 expression in the colorectum: Correlation with morphological features of adenomatous lesions

British Journal of Biomedical Science

Volumn 63, Issue 2, 2006, Pages 68-73

  Woodland, James G ^a  

^a ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

Author keywords

Adenomatous polyps; CDX 2; Dysplasia; Proliferation

Indexed keywords

KI 67 ANTIGEN; TRANSCRIPTION FACTOR CDX2;

ADENOMATOUS POLYP; ARTICLE; CELL PROLIFERATION; COLORECTAL ADENOMA; CONTROLLED STUDY; DYSPLASIA; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MORPHOLOGICAL TRAIT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CLASSIFICATION;

MURINAE;

EID: 33746291904     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2006.11732723     Document Type: Article

References (38)

1. Cooper HS. Benign epithelial polyps of the intestines. In: Ming SC, Goldman H, eds. Pathology of the gastrointestinal tract (2nd edn). Maryland, US: Williams and Wilkins, 1998: 819-53.
2. Allum WH, Griffin SM, Watson A et al. Guidelines for the management of oesophageal and gastric cancer. Gut 2002; 50 (Suppl V): v1-v23.
3. Gryfe R, Swallow C, Bapat B et al. Molecular biology of colorectal cancer. Curr Probl Cancer 1997; 21 (5): 233-300.
4. Clevers H. Wnt breaks in colon cancer. Cancer Cell 2004; 5 (1): 5-6.
5. Lovig T, Thorstensen B, Hofstad S et al. Genetic and protein markers related to in situ growth and multiplicity in small sporadic colorectal adenomas. Scand J Gastroenterol 2003; 3: 298-306.
6. Rickert RR, Auerbach O, Garfinkle L et al. Adenomatous lesions of the large bowel and colon: an autopsy survey. Cancer 1979; 43: 1847-57.
7. Shinya H, Wolff WI. Morphology, anatomic distribution and cancer potential of polyps: an analysis of 7000 polyps endoscopically removed. Ann Surg 1979; 190: 679-83.
8. Akedo I, Ishikawa H, Ioka T et al. Evaluation of epithelial cell proliferation rate in normal appearing colonic mucosa as a high risk marker for colorectal cancer. Cancer Epidemiol Biomarkers Prev 2001; 10: 925-30.
9. Paspatis GA, Zizi A, Chlouverakis GJ et al. Proliferative patterns of rectal mucosa as predictors of advanced colonic neoplasms in routinely processed rectal biopsies. Am J Gastroenterol 1998; 93 (9): 1472-7.
10. Hao X, Du M, Bishop A et al. Imbalance between proliferation and apoptosis in the development of colorectal carcinoma. Virchows Arch 1998; 433: 523-27.
11. Nomura M, Watari J, Yokota K et al. Morphogenesis of nonpolypoid colorectal adenomas and early carcinomas assessed by cell proliferation and apoptosis. Virchows Arch 2000; 437: 17-24.
12. Sheikh R, Min BH, Yasmeen S et al. Correlation of Ki-67, p53 and Adnab-9 immunohistochemical staining and ploidy with clinical and histopathological features of severely dysplastic colorectal adenomas. Dig Dis Sci 2003; 48: 223-9.
13. Sugao Y, Koji T, Yao T et al. The incidence of apoptosis during colorectal tumourogenesis. Int J Surg Pathol 2000; 8 (2): 123-32.
14. Valassiadou KE, Stefanaki K, Vlachonikolis I et al. Immunohistochemical expression of MIB1 (KI-67) protein in colorectal adenocarcinomas. E J Pathol
15. Kikuchi Y, Dinjens WNM, Bosman FT. Proliferation and apoptosis in proliferative lesions of the colon and rectum. Virchows Arch 1997; 431: 111-7.
16. Ikenaga M, Takano Y, Ohtani Y et al. Low levels of apoptosis and proliferative activity in colorectal villous tumours: comparison with tubular tumours. Pathol Int 1998; 48: 453-9.
17. Devaprasath A, Chacko G. Diagnostic validity of the Ki-67 labelling index using the MIB-1 monoclonal antibody in the grading of meningiomas. Neurol India 2003; 51: 336-40.
18. Kruse A-J, Baak JPA, De Bruin PC et al. Ki-67 immunoquantitation in cervical intraepithelial neoplasia (CIN): a sensitive marker for grading. J Pathol 2001; 193: 48-54.
19. Lindboe CF, Torp SH. Comparison of Ki-67-equivalent antibodies. J Clin Pathol 2002; 55: 467-74.
20. Suh E, Traber PG. An intestine-specific homeobox gene regulates proliferation and differentiation. Mol Cell Biol 1996; 16(2): 619-25.
21. Mark M, Rijli FM, Chambon P. Homeobox genes in embryogenesis and pathogenesis. Pediatr Res 1997; 42 (4): 421-9.
22. Maulbecker CC, Gruss P The oncogenic potential of deregulated homeobox genes. Cell Growth Differ 1993; 4 (5): 431-41.
23. Wicking C, Simms L, Evans T et al. CDX-2, a human homologue of Drosophila caudal, is mutated in both alleles in a replication error-positive colorectal cancer. Oncogene 1998; 17 (5): 657-9.
24. Abate-Shen C. Deregulated homeobox gene expression in cancer: cause or consequence? Nat Rev Cancer 2002; 2 (10): 777-85.
25. Almeida R, Silva E, Santos-Silva F et al. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J Pathol 2003; 199: 36-40.
26. James R, Erler T, Kazenwadel J. Structure of the murine homeobox gene CDX-2. J Biol Chem 1994; 269 (21): 15229-37.
27. Brittan M, Wright NA. Stem cell in gastrointestinal structure and neoplastic development. Gut 2004; 53: 899-910.
28. Tamai Y, Nakajima R, Ishikawa T et al. Colonic hamartoma development by anomalous duplication in Cdx2 knockout mice. Cancer Res 1999; 59: 2965-70.
29. Seno H, Oshima M, Taniguchi M-A et al. CDX2 expression in the stomach with intestinal metaplasia and intestinal type cancer: prognostic implications. Int J Oncol 2002; 21: 769-74.
30. Satoh K, Mutoh H, Eda A et al. Aberrant expression of CDX2 in the gastric mucosa with and without intestinal metaplasia: effect of eradication of Helicobacter pylori. Helicobacter 2002; 7 (3): 192-8.
31. Mizoshita T, Tsukamoto T, Inada K-I et al. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa. Pathol Int 2004; 54: 392-400.
32. Mallo GV, Rechreche H, Frigerio J-M et al. Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis. Int J Cancer 1997; 74: 35-44.
33. Freund J-N, Domon-Dell C, Kedinger M et al. The Cdx-1 and Cdx-2 homeobox genes in the intestine. Biochem Cell Biol 1998; 76: 957-69.
34. da Costa LT, He T-C, Yu J et al. CDX-2 is mutated in a colorectal cancer with normal APC/β-catenin signaling. Oncogene 1999; 18: 5010-4.
35. Ee HC, Erler T, Bhatal PS et al. Cdx-2 homeodomain protein expression in human and rat colorectal adenoma and carcinoma. Am J Pathol 1995; 147 (3): 586-92.
36. Brabletz T, Spaderna S, Kolb J et al. Down-regulation of the homeodomain factor Cdx2 in colorectal cancer by collagen type I: an active role for the tumour environment in malignant tumour expression. Cancer Res 2004; 64: 6973-7.
37. Hinoi T, Loda M, Fearon ER. Silencing of CDX2 expression in colon cancer via a dominant repression pathway. J Biol Chem 2003; 45 (7): 44608-16.
38. Leake R, Barnes D, Pinder S et al. Immunohistochemical detection of steroid receptors in breast cancer: a working protocol. J Clin Pathol 2000; 53 (8): 634-5.